SOTAC PHARMACEUTICALS
Back to Cashflow Statement
|
SOTAC PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-4.33 Cr | ₹-16 Cr | ₹8.14 Cr | ₹6.35 Cr | ₹-0.31 Cr |
What is the latest Cash Flow from Operating Activities ratio of SOTAC PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-4.33 Cr |
| Mar2024 | ₹-16 Cr |
| Mar2023 | ₹8.14 Cr |
| Mar2022 | ₹6.35 Cr |
| Mar2021 | ₹-0.31 Cr |
How is Cash Flow from Operating Activities of SOTAC PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4.33 Cr | Negative | |
| Mar2024 | ₹-16 Cr | Negative | |
| Mar2023 | ₹8.14 Cr | 28.22 | |
| Mar2022 | ₹6.35 Cr | Positive | |
| Mar2021 | ₹-0.31 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹123.3 Cr | -9.2% | -12.8% | -10% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -9.2% |
-12.8% |
-10% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses